According to the Program for the Medicalization of Information Systems (PMSI), the total number of patients hospitalized for shingles or postherpetic neuralgia was 36,198 between 2008 and 2021 in France, for an average of 2,586 patients per year. The breakdown by gender showed a slight predominance of women: they accounted for 58% of patients, compared with 42% for men. The age groups with the highest number of cases were: those aged 80–84 (16%), those aged 85–89 (16%), those aged 74–79 (12%), and those aged 90 and older (11%). During the study period, people aged 65 and older accounted for 72% of hospitalized cases, and those aged 50 and older accounted for 88%. ; The types of shingles most frequently coded in the PMSI were: uncomplicated shingles (42%), ophthalmic shingles (19%), shingles with other complications (17%), and shingles accompanied by other neurological manifestations (12%). Other types of shingles accounted for less than 10% of hospitalized cases. The most severe forms (herpes zoster meningitis and encephalitis) were less common, each accounting for 2% of hospitalized cases. Hospitalizations for postherpetic neuralgia accounted for only 7% of cases. ; Between 2008 and 2021, the average annual incidence rate of hospitalized cases over the 14-year period was 4.65 cases per 100,000 population for shingles and 0.37 cases per 100,000 population for postherpetic neuralgia. The trend in the incidence of hospitalized cases over the period was generally stable. For shingles, incidence rates ranged from a low of 4.18 in 2008 to a high of 5.14 per 100,000 inhabitants in 2019. For DPZ, rates ranged from a low of 0.31 in 2010 to a high of 0.47 per 100,000 inhabitants in 2018. ; Incidence rates by age group increased sharply with age, regardless of sex. For shingles: the incidence rate of hospitalized cases for shingles was 8 times higher among those aged 65 and older compared to those aged 18–64: 14.07 per 100,000 population versus 1.76, respectively. For DPZ: the rate was 15 times higher for those aged 65 and older compared to those aged 18–64: 1.31 per 100,000 inhabitants versus 0.09, respectively. ; The four regions reporting the highest incidence rates of hospitalized cases were Bourgogne-Franche-Comté, Brittany, Nouvelle-Aquitaine, and Normandy. The regions reporting the lowest incidence rates were Corsica and the overseas departments.; Analysis of the number of hospitalized cases per month over the 14 years studied did not reveal any seasonality.; The average length of stay was 8.6 days (median of 7 days). Women stayed longer on average than men: 9 days versus 8. Advanced age was associated with a longer length of stay: it was less than 7 days for those under 50 and 10 days or more for those over 80. ; The most severe forms of shingles generally resulted in a longer length of stay. Immunocompromised patients had a longer average length of stay than immunocompetent patients: 10 versus 8 days, respectively. ; Among the 36,198 cases hospitalized for shingles between 2008 and 2021, 554 deaths were reported; this represents 1.5% of shingles hospitalizations with a fatal outcome and an average of 40 in-hospital deaths per year. Patients aged 85 and older accounted for 60% of deaths, and those aged 70 and older accounted for 90% of deaths. Adults under 65 accounted for only 6% of deaths among hospitalized cases; the in-hospital case fatality rate increased with age. However, within the same age group, it was consistently higher among immunocompromised patients. Among those aged 50–74, the case fatality rate for immunocompromised patients was 5 to 9 times higher than that for immunocompetent patients. ; 27% of hospitalized cases involved immunocompromised patients. 41% (226/554) of deaths from shingles or postherpetic neuralgia involved immunocompromised patients. Among the 9,716 immunocompromised patients identified, 226 died during their hospital stay, representing a case-fatality rate of 2.3% compared with 1.2% among immunocompetent patients.